Unicycive Therapeutics, Inc. · NASDAQ:UNCY

Unicycive Therapeutics, Inc. financial statements

Unicycive Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue00675.0K951.0K000
Cost of revenue572.0K428.0K284.0K7.00K1.00K
Gross profit-572.0K-428.0K675.0K951.0K-1.00K
Research and development9.12M20.0M12.9M12.4M6.08M1.01M795.0K344.0K
Selling, general and administrative20.4M12.1M8.55M383.0K245.0K58.0K1.17M608.0K
Operating income-29.5M-32.1M-20.8M-18.1M-8.98M-2.02M-1.96M-952.0K
Depreciation and amortization34.0K22.0K9.00K428.0K468.0K63.0K1.96M952.0K
EBITDA-29.5M-32.1M-20.8M-17.6M-8.51M-1.96M00
Interest expense71.0K71.0K82.0K6.00K628.0K244.0K139.0K0
Income before tax-26.6M-36.7M-30.5M-18.1M-10.0M-2.26M-2.17M-1.12M
Income tax-1.09M116.1K6.00K615.0K244.0K139.0K-952.0K
Net income-26.6M-36.7M-30.5M-18.1M-10.0M-2.26M-2.30M-1.12M
Earnings per share, basic-1.67-5.65-1.28-1.20-0.86-0.27-1.51-0.73
Earnings per share, diluted-1.67-5.65-1.28-1.20-0.86

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents29.2M26.1M9.70M455.0K16.6M015.0K25.0K
Short-term investments12.1M0
Inventory2.19M1.83M
Current assets49.0M30.9M13.4M2.64M18.4M204.0K19.0K29.0K
Property, plant and equipment66.0K75.0K26.0K22.0K28.0K
Total assets49.1M31.7M14.2M2.82M18.7M204.0K19.0K29.0K
Accounts payable383.0K1.06M839.0K892.0K742.0K184.0K322.0K60.0K
Current liabilities18.9M24.1M17.5M3.28M2.10M2.88M903.0K1.24M
Total debt199.0K773.0K811.0K201.0K335.0K2.51M460.0K1.05M
Total liabilities18.9M24.2M18.0M3.28M2.26M2.88M903.0K1.24M
Shareholders' equity30.2M7.43M-3.81M-466.0K16.5M-2.67M-884.0K-1.21M
Shares outstanding22.1M11.4M34.8M15.2M15.0M8.51M1.52M1.52M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-31.3M-28.6M-18.3M-15.7M-5.77M-1.46M-1.18M-775.0K
Capital spending-24.0K-72.0K-12.0K-2.00K-29.0K-29.0K-29.0K-29.0K
Free cash flow-31.3M-28.6M-18.3M-15.7M-5.80M-1.46M-1.18M-775.0K
Cash from investing-12.1M-72.0K-12.0K-2.00K-29.0K-29.0K-29.0K-29.0K
Cash from financing46.5M45.1M27.5M-471.0K22.4M1.44M1.17M800.0K
Dividends paid0-1.09M-900.0K
Change in cash3.06M16.4M9.25M-16.1M16.6M-15.0K-10.0K25.0K